APA

Müller V., Thomssen C., Schmidt M., Glados M., Jackisch C., Heilmann V., Hinke A., Lehnert A., Borowicz H. & Möbus V. (20110203). Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer. : BMC cancer.

Chicago

Müller Volkmar, Thomssen Christoph, Schmidt Marcus, Glados Manfred, Jackisch Christian, Heilmann Volker, Hinke Axel, Lehnert Antje, Borowicz Henryk and Möbus Volker. 20110203. Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer. : BMC cancer.

Harvard

Müller V., Thomssen C., Schmidt M., Glados M., Jackisch C., Heilmann V., Hinke A., Lehnert A., Borowicz H. and Möbus V. (20110203). Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer. : BMC cancer.

MLA

Müller Volkmar, Thomssen Christoph, Schmidt Marcus, Glados Manfred, Jackisch Christian, Heilmann Volker, Hinke Axel, Lehnert Antje, Borowicz Henryk and Möbus Volker. Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer. : BMC cancer. 20110203.